General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

CANbridge ×

CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.

  • Sector: Life Sciences
  • Headquarters: Beijing, China
  • Date Invested: 03/10/2020
  • Visit Website